股票 › ORKA
奥鲁卡治疗 ORKA
美股市值排名 #1780
$102.86 +$6.84 (+7.12%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $103.90 +1.01%
开盘$97.99
昨收$96.02
当日区间$96.05 – $103.78
成交量1.07M
市值$6.81B
市盈率（TTM）–
股息率–
ORKA 相关新闻
匹配 Oruka Therapeutics 或代码 ORKA 的头条新闻，按最新排序。
- LifeSci Capital Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $175
- H.C. Wainwright Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $120
- Wedbush Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $165
- A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $120 to $175
- Barclays Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $160
- UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Fractyl Health, Inc. (GUTS) and Oruka Therapeutics (ORKA)
- TD Cowen Maintains Oruka Therapeutics(ORKA.US) With Buy Rating
- Piper Sandler Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $180
- A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $133 to $180
- A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $151 to $200
- LifeSci Capital Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $125
- Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)
- UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Raises Target Price to $130 正面
- Stifel Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $150
暂无评论——快来第一个聊聊 ORKA。
登录后参与讨论。